Sweden’s highest administrative court has overturned an earlier judicial decision allowing the country’s national drug agency to ban the sale of e-cigarettes.
Companies wanting to distribute electronic cigarettes in Sweden have previously required a stamp of approval from the country’s Medical Products Agency (Läkemedelsverket), which has also been able to ban sales.
But on Wednesday, Sweden’s Supreme Administrative Court ruled that e-cigarettes are not medical products and therefore the agency could not oppose its sale.
“To be a medical product, it must have the ability to prevent or treat a disease and, therefore, provide a beneficial effect on human health,” the court’s ruling read.
The e-cigarettes “do not contain instructions on how they could be used to reduce the consumption of cigarettes or nicotine addiction”, according to the court.
E-cigarettes are battery-powered devices that heat up a liquid containing nicotine and artificial flavouring. The vapour is inhaled – “vaped” – and exhaled, much like a cigarette.
In the last few years, health experts and watchdogs have been embroiled in debate as to whether the gadgets, often not strictly regulated, are safe.
They can also be used with nicotine-free liquids, but some fear e-cigarettes could be a gateway to “real” cigarettes for teenagers.
Regulations concerning e-cigarettes are changing rapidly and vary widely throughout Europe.
Upgrade! Upgrade! Upgrade! Our life is upgrading all the time, is that what we really want—higher and stronger performances, more and more functions? We couldn’t stop to ask ourselves: what do we really want?
Stick One pays homage to classic style and allow you to return to the simple age.
Vaping is a lifestyle.
Simple is enough.
2 EDITIONS FOR YOU
Stick One has two editions: Stick One Basic Kit and Stick One Plus Kit.
Stick One Basic Kit is made up of the newest SMOK Nano TFV4 Tank and the classic eGo Cloud Battery (2200 mAh).
Stick One Plus Kit is made up of the Micro TFV4 Plus Tank and eGo Cloud Plus Battery (2000 mAh).
Under their simple and stylish design, there are perfect taste, reliable performance and long battery life for vaping all day. Aha, revive the original pursuit.
STICK ONE BASIC KIT
STICK ONE PLUS KIT
LIGHT AND PORTABLE, PERFECTLY FIT IN ONE HAND
Stick One Basic Kit and Stick One Plus Kit have been minimized to the extreme! They are portable, lightweight and comfortable to hold.
REVIVAL OF CLASSIC, REMARKABLY TRUE TO LIFE
Nano TFV4 and Micro TFV4 Plus are the upgraded version of SMOK TFV4 Tank. They build upon the original features like top refill system and double-layered drip tip. With two sub-ohm cores: 0.3Ω Micro CLP2 Core and 0.25Ω Micro STC2 Core, they will give you perfect taste!
TOP REFILL SYSTEM, FILLING IN ONE GO
Nano TFV4 & Micro TFV4 Plus top refill system with hinge lock, you just need to swivel the top cap, and then fill easily. And the leak proof e-liquid slot can significantly solve leaking problem.
It’s no secret that smoking is bad for your heart. In fact, smokers are twice as likely to suffer heart attacks and they face increased risks for strokes and coronary heart disease.Research shows that smoking can actually damage the lining of your arteries, reduce the amount of oxygen in your blood, and force your heart to work harder just to maintain normal function. So what happens if you switch from smoking to vaping? According to the latest research, it can dramatically improve your cardiovascular health.
In a new study pioneered by Dr. Konstantinos Farsalinos, researchers recruited a group of smokers and offered them the chance to switch to vaping. Scientists monitored their progress for a full year. By the end of the study, some had completely quit smoking, others had reduced their cigarette use dramatically, and some had continued tobacco use with no major changes. Those who had completely switched to vaping or reduced their tobacco consumption by both smoking and vaping experienced major changes to their heart health.
Many of the smokers had worrisome hypertension at the beginning of the study. But after switching completely to vaping, there was an average decline in systolic blood pressure of 16.3 mm Hg. Those who were dual users (both vaping and smoking) also lowered their blood pressure by an average of 10.8 mm Hg.
Perhaps most interesting of all, the researchers found that those who quit smoking and vaping completely had no further decrease in their blood pressure than those who ditched cigarettes and substituted with vaping. Ultimately, just by trading tobacco cigs for vapor devices, participants were able to continue the experience of smoking while experiencing dramatic benefits to their cardiovascular health.
This study is significant because it contradicts several previous misconceptions about vaping. Many health advocates have claimed that when smokers switch the vaping, they still experience increased cardiovascular risk because they still use nicotine. This study proves that this simply isn’t true.
Furthermore, it shows that vaping is in fact a legitimate alternative to smoking and it allows tobacco users a reasonable way to successfully kick the habit and improve their health dramatically. The study also offers proof that dual use is not necessarily the end of the world. We’ve heard vapor critics argue that dual use will only increase nicotine consumption, thereby doing more harm than good. However, this new study shows that even when smokers manage to cut their tobacco consumption in half by vaping, they still experience significant drops in blood pressure and cardiovascular risk.
Ultimately, this new study gives us just one more look at the potential ways that vaping can change the world. If vaping can help current smokers reduce their risk for heart attack and stroke, why isn’t every doctor in the world recommending this alternative?
The news media loves to talk about the dangers of vaping, even the fictional dangers that don’t scientifically exist. This isn’t a surprise, or at least it shouldn’t be. We all know that the media has a much better time with their ratings if they are scaring people. Just imagine you see a teaser for the news. It has ominous music and the narrator says “ecigs are very trendy, but the dangers of vaping are real and we’ll tell you about them tonight on the 10 o’clock news.” Think people are going to tune in to find out?
Of course they are. That’s just how the media game works and it is something you pick up on quite quickly if you just pay a little attention. That’s how the “if it bleeds, it leads” phrase became so well known. When that average American does turn on his or her nightly news broadcast feature about electronic cigarettes, they will undoubtedly be flooded with a bunch of scary threats. Lots of rumor and assumptions will come up and very soon they will end up thinking that the dangers of vaping are terrible. At the least, they’ll think that the benefits are far outweighed by those dangers.
There will obviously be comparisons made the analogue cigarettes, but they’ll stress the similarities. They’ll tell you how you are still ingesting nicotine and they’ll paint it in a way that leads you to believe nicotine is bad for you. In fact, that isn’t really the truth at all. They may tell you that there are dangers of second hand vaping, just like second hand smoke. Once again, that isn’t the truth either and nobody has scientifically proven that it is. All of these claims about the dangers of vaping are made by connecting dots that don’t really connect. But there is one danger that we know exists, and that is the one you should really be focusing on.
Real Dangers Of Vaping Products Exploding
Batteries are at the heart of the dangers of vaping, but it isn’t as if you should stop vaping (or not start at all). While the dangers of second hand vaping is pretty much a myth, there is real solid proof of this phenomenon of ecig batteries exploding.
We won’t paint a pretty picture here, because the reality is that it is beginning to get out of hand. Just in last week we have seen numerous news reports of people being injured by exploding ecig batteries.
But the news of an explosion that injured a mother of two in England and the one that injured a teenager in Canada are related. Just like they are related to the man in New Hampshire who suffered burns due to an ecig exploding. All of these incidents have to do with the real dangers of vaping; buying bad products.
We don’t mean bad products because they are overpriced. Nor do we mean to say they just don’t taste good or don’t produce the amount of vapor you want. No, we mean bad products because they don’t go through proper quality control. While most electronic cigarettes are made at least partly in China, there is a mammoth difference between purchasing from a reputable brand and something on a non-branded site or simply from ebay. It may be cheaper, but it heightens the dangers of vaping exponentially.
It’s true that sometimes there are faulty products and that can happen in any industry. But there is also a reason we don’t see anything negative like this in the news about any of the top brands we recommend. These are companies that have a reputation to uphold and so they take all the necessary precautions, and even the precautions that aren’t necessary. Whether driven out of a concern for their consumers or a concern for their public image, you’ll be hard-pressed to see anyone working harder to make sure that the product you buy doesn’t fail in such a dramatic way as to explode or otherwise put you in danger.
The other thing that is going on is the serious concern regarding counterfeit ecigs. Fakes are everywhere. The dangers of vaping have been exacerbated by the sheer volume of clone ecigs on the market. You will find cloned ecigs and vaping products all over the internet and sometimes even in vape shops. How bad is the problem? Here are some numbers that will shock most of you.
There are a handful or world-class ecig manufacturers in China. Eight Aspire, Kangertech, Smok, Innokin, Joyetech and a few others are exceptional. They make some of the best vaping products in the world. They have strict quality control and use only the best materials. These companies are located in an industrial area of Shenzhen, China. Within that same are are 600 ecig factories. 600!
Most of those factories are producing terrible knockoffs at rock bottom prices. The fakes look just like the real thing. They are being sold online through a number of retail and wholesale websites. Even vape shop owners are being fooled by some of these products. This is a serious problem and results in a lot of bad press for the industry when one of these clone ecigs is the root cause of some well publicized ecig accident.
If you are interested in a Kanger, Aspire, Joyetch product, you need to buy from a reputable source that knows what they are doing. The vaping business is booming and pretenders and fakes are trying to cash in as are the brands that are just blatantly selling junk! With no regulation in place it is buyer beware.
The real culprit here is greed. The dangers of second hand vaping aren’t real, nor are all these other accusations that just stoke people’s fears. No, the dangers of vaping lie in cheap ecigs. That’s why the FDA should be worried about cheap ecigs instead of fruity ecig flavors. As a consumer, make sure that these harrowing stories in the news don’t put you off from making the switch to vapor. All you have to do is make sure you buy from the right sources and you’ll be well on your way to leaving traditional tobacco cigarettes behind you, as well as ridiculous claims about the dangers of vaping.
The Artist Collection is a refined palette of masterful flavors expressed through sophisticated devices. Graced with nuance and subtlety, this exclusive new line of liquids presented is crafted by five leading artists in the vape industry, partnered with NJOY in the fight against big tobacco. Premium artists equal premium quality. These top-of-the-line mist makers bring out the best in taste and sensation because they pursue vaping with passion. Now it’s time to pursue yours.
A five-year, first-in-Canada study, led by McGill cardiologist Dr. Mark Eisenberg, is exploring whether vaping really is the magic ticket to finally breathing free and easy.
By James Martin
Although the holidays may seem like a distant memory, statistically speaking, most of us are still sticking with our New Year’s resolutions. (For now. Let’s not talk about how many of us last until July.) For many, that means quitting smoking — and they’re hoping that electronic cigarettes will help. According to the U.S. Centers for Disease Control and Prevention, nearly half of all American smokers have tried e-cigarettes to help them kick the habit. But Dr. Mark Eisenberg wants to know: Is vaping really the magic ticket to breathing free and easy?
Dr. Eisenberg is passionate about getting people to butt out. He gives a lot of smoking cessation talks — just last month, he spoke at the Jewish General Hospital, where he is staff cardiologist — and has noticed that, invariably, reformed smokers come up to him afterward to sing the praises of e-cigarettes, those increasingly popular handheld battery-operated vaporizers that mimic conventional cigarettes.
“They say, ‘I smoked for decades and I’ve tried everything — nicotine gum, patches, Zyban, Champix — and I couldn’t stop. Then I picked up an e-cigarette and I never smoked again,’” recalls Eisenberg, who is also a professor in McGill’s Faculty of Medicine and director of the Joint MD/PhD program. “Anecdotally, we have many, many cases like this.”
What doctors don’t have, however, is hard data to back it up. That’s why, this month Eisenberg will start a five-year clinical trial to look at how effective e-cigarettes are at aiding smoking cessation. It’s not just smokers and physicians who are interested in such clarity — so are lawmakers. Under Canada’s Food and Drug Act, e-cigarettes containing nicotine cannot be imported, advertised or sold without Health Canada’s approval; nicotine-free e-cigarettes are not restricted. Although Health Canada has yet to grant such approval, nicotine-loaded e-cigarettes are nevertheless widely and openly available in Canada.
The study, which is funded by the Canadian Institutes of Health Research (CIHR), will follow 486 outpatient smokers at 19 sites across Canada. The smokers will be randomized into three groups. One group will be given e-cigarettes that contain nicotine and counselling. The second group will receive e-cigarettes that do not contain nicotine, and counselling. The third group will only receive counselling. The researchers will supply the smokers with e-cigarettes for 12 weeks, and then follow up with them after six months and a year, observing whether they graduate to total non-smoking, continue with the e-cigarettes, or return to conventional cigarettes. Although some reformed smokers may fall off the wagon after a smoke-free year, Eisenberg clarifies that “statistically significant results at 12 months would still be important evidence” for the efficacy of e-cigarettes as a cessation aid. All 486 patients will not be enrolled simultaneously, with the study expected to roll out over the course of five years.
“The ultimate goal is to use the e-cigarette as a transitional tool in going from smoking conventional cigarettes to not smoking at all,” says Eisenberg. He notes that, at least in the early stages, e-cigarettes are about “transferring the addiction. You’re getting people onto something else that is giving them their nicotine, so they may never quit. E-cigarettes also provide other physical and social aspects because they feel like a cigarette; a pack-a-day smoker makes that hand-to-mouth motion more than 70,000 times a year, for example. That’s a difficult thing to break away from, and a nicotine patch doesn’t provide it.
“We have great hopes that e-cigarettes will be helpful for people trying to quit smoking,” he adds. “Even if they just switch to smoking e-cigarettes that would be better than continuing to smoke conventional cigarettes for decades. I’m not saying that e-cigarettes are safe, but they’re much safer than conventional cigarettes. They’re not going to give you lung cancer. They’re not going to give you heart disease. They’re not going to give you emphysema.
“But what we’re really hoping for is that e-cigarettes lead people to not smoking altogether.”
(This particular study, Eisenberg notes, is not designed to investigate safety concerns, such as whether e-cigarette vapour contains trace elements of harmful substances. Other than their smoking habits, the trial’s participants are healthy, he explains, “so the chances that they’d have adverse effects over a short time like the course of one year are quite low.” The researchers will, however, track whether the smokers are hospitalized for any cardiopulmonary issues. They will also gather data about benign side effects, such as throat irritation.)
E-cigarettes are already big business, ringing up an estimated $500-plus million in sales in the U.S. alone — and that’s without being able to make any claims about helping smokers kick their habits. Eisenberg says that the e-cigarette industry itself isn’t clamouring to make such claims: “They don’t want to be regulated by the Food and Drug Administration [in the U.S.] and Health Canada, so they don’t want to support clinical trials,” he says. “And they don’t need to: Smokers are voting with their feet by buying e-cigarettes to help them quit smoking.” Governments, however, want more than anecdotal evidence.
“This study alone would not be enough for Health Canada to allow companies to market e-cigarettes as smoking cessation aids,” explains Eisenberg. “That said, if this trial shows that there is a substantial reduction in smoking traditional cigarettes, then Health Canada will have to rethink their policy.
“This is just a first step. Then we would need multiple big trials in multiple populations. We would need to use tapering [of nicotine levels] studies, and we would need to use interventions that are longer than 12 weeks. But the fact is that smoking is still the single most reversible cause of mortality in Canada — so it’s an important first step.”
People trying to give up smoking often use e-cigarettes to help wean themselves off tobacco. Most experts think they are safer than cigarettes but a surprising paper was published recently – it suggests that people who use e-cigarettes are less successful at giving up smoking than those who don’t.
The study causing the fuss was written by researchers at the Center for Tobacco Control Research and Education at the University of California, and published in one of the Lancet’s sister journals, Lancet Respiratory Medicine.
It is a meta-analysis, which means the authors reviewed the academic literature already available on the topic. They sifted out the weaker papers – ones that didn’t have control groups, for example – and were left with 20.
The conclusion? Smokers who use e-cigarettes have a 28% lower chance of quitting than smokers who don’t use them, according to Prof Stanton Glantz, one of the authors.
But while the conclusion is surprising, so is the number of academics who have criticised the paper.
One was Ann McNeill, professor of tobacco addiction at Kings College London, whose own research is included in Glantz’s analysis.
“The information… about two studies that I co-authored is either inaccurate or misleading… I believe the findings should therefore be dismissed.
“I am concerned at the huge damage this publication may have – many more smokers may continue smoking and die if they take from this piece of work that all evidence suggests e-cigarettes do not help you quit smoking; that is not the case.”
Prof Peter Hajek, director of the Tobacco Dependence Research Unit at the Wolfson Institute also called the findings “grossly misleading”.
The critics are making three main points. First, the definition of e-cigarettes is a bit loose. There are many different types – some look like cigarettes, others have tanks for the vaping liquid, some are disposable and other are multi-use. They all deliver different doses of nicotine. Many of the papers included in the analysis don’t specify which type people are using, according to Linda Bauld, professor of health policy at the University of Stirling.
Another point is that the studies vary in the way they measure how often people use e-cigarettes. “Some only assessed whether a person had ever tried an e-cigarette or if they had tried one recently, not whether they were using it regularly or frequently,” Bauld says.
Even the paper’s author admits it’s possible that in some of the studies e-cigarettes may only have been used once, which he says would not be a good predictor of whether they had affected people’s ability to stop smoking.
And there is another problem. You might expect, if you were going to draw conclusions about how useful e-cigarettes are in helping people quit, to focus on studies looking at people who are trying to give up.
Prof Robert West, who heads a team at University College London researching ways to help people stop smoking, says this analysis mashed together some very different studies – only some of which include people using e-cigarettes to help them quit.
“To mix them in with studies where you’ve got people using an e-cigarette and are not particularly trying to stop smoking is mixing apples and oranges,” he says.
Some of the studies track smokers who use e-cigarettes for other reasons – perhaps because smoking a cigarette in a bar or an office is illegal and they want a nicotine hit.
“With the studies where people are using electronic cigarettes specifically in a quit attempt the evidence is consistent,” says West, referring to two randomised control trials.
Both are quite small and one was funded by the e-cigarette industry. They took two groups of smokers, and gave one real e-cigarettes, and the other a placebo. The studies reach a broadly similar conclusion to a large, real-world study called the Smoking Toolkit run by West.
West’s investigation follows people in their daily lives and assesses how successful various methods of giving up smoking are – this includes nicotine patches, medicines and going cold turkey.
These studies suggest that people using e-cigarettes to help them quit are 50% to 100% more successful than those who use no aids at all.
In his paper, Glantz acknowledges there are limitations to the research that he analysed. He agrees there are problems with the way the use of e-cigarettes is measured and accepts it’s not clear which devices people are using. But he is sticking by his analysis because he believes he has taken these factors into account.
The editor of Lancet Respiratory Medicine, Emma Grainger, defends the article too. She says she does not see a problem with the paper and that it has been through the normal peer-review process.